46
Growth Score
pts
Heat Score
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1184038
RevaTis provides treatments in regenerative medicine such as the production and the preventive biobanking of autologous stem cells.
- Didier Serteyn: CEO
About the Company
RevaTis provides treatments in regenerative medicine such as the production and the preventive biobanking of autologous stem cells. it promotes the use by partners of its aseptic isolators packaged in a complete ‘turnkey’ system that includes quality management system and electronic batch record, making it fully GMP compliant.
RevaTis, a spin-off
from Liege University, in Belgium, was founded end 2013 and focuses on advanced regenerative medicine and cell therapy. Its growth is underpinned by its innovative and patented technology to obtain pluripotent adult Mesenchymal Stem Cells from a minimally invasive muscle micro-biopsy.
